AzTrials
AzTrials

Drug UseNCT06132555

Health Status and the Need for Social Return of Drug Abusers in Guangdong Province

An observational study of Drug Use, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study intends to conduct a secondary analysis of the data from the investigation on the status quo of anti-drug rehabilitation work and management needs in Guangdong Province. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Drug Use
What is being tested?
Online questionnaire survey, In-depth personal interview and Colloquia
How many people
7,106 participants
Where
1 siteChina
Study dates
15 Nov 2023to Aug 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Drug abusers who registered in any of a streets or townships of Guangdong Province would be selected.

Who may be able to join

  • Cities in Guangdong Province are selected according to the geographical distribution, development level, economic level and population distribution of the cities.
  • Drug abusers who registered in any of a streets or townships of Guangdong Province would be selected.
  • Drug abusers who have abstained for more than 3 years.
  • All age groups under 30 years old, between 30 and 50 years old and over 50 years old were covered.

Who cannot join

  • Eliminate more than 20 questions missed or not answered questionnaires.
  • The questionnaires which be filled out by the same respondent repeatedly.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Sun Yat-sen University

    Guangzhou, Guangdong, 510080

Other trials in China

About this study

Official title: Health Status and the Need for Social Return of Drug Abusers in Guangdong Province: a Secondary Data Analysis Study

This study intends to conduct a secondary analysis of the data from the investigation on the status quo of anti-drug rehabilitation work and management needs in Guangdong Province.

Read the detailed description

The drug problem is a major problem that threatens individuals' physical and mental health, family happiness, national security, regional stability and world peace. In recent years, anti-drug departments in various regions of Guangdong Province have adhered to the arrangement and deployment of the National Anti-Drug Office, the provincial Party committee and the provincial government and the Party committee of the Public Security Department, focused on preventing the harm of synthetic drugs, improved the system, implemented responsibilities, and innovated methods, and constantly improved the anti-drug and drug rehabilitation work in Guangdong.

Nowadays, with the improvement of the level of social and economic development, the personnel structure and characteristics of drug abusers in Guangdong Province have undergone corresponding changes, and the effect of the existing control policies on drug abusers has also shown a weak stage, which needs to be adjusted and updated in time.

In this context, Guangdong Provincial Public Security Department has carried out research on anti-drug management countermeasures, and actively discussed the status quo, difficulties and reform direction of anti-drug management in the new era.

This study intends to conduct a secondary analysis based on the data obtained from the investigation and research on the status quo of drug control and detoxification work and management needs in Guangdong Province, aiming to describe the demographic and sociological characteristics of drug abusers in Guangdong Province, as well as their psychosocial experience of receiving interpretation intervention and the status quo of social regression needs. What's more, this study also devoted to forming a practical multi-department co-management model of community comprehensive management of drug addicts in Guangdong Province in the new era, to comprehensively improve the management level of drug abusers in Guangdong Province, serving grassroots communities, and build a harmonious society.

Conditions
Drug Use
Being tested
Online questionnaire survey, In-depth personal interview, Colloquia
Keywords
drug abuser, health condition, social regression, secondary data analysis
Medical subject headings
Drug Misuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online questionnaire surveyOther

    The investigators have made an electronic questionnaire through the questionnaire star, and send the link or two-dimensional code of the electronic questionnaire to the subjects through WeChat or SMS to remind them to fill in the answer on the mobile phone or computer.

    The questionnaire consisted of four parts: (1) basic information of the interviewees, (2) drug abuse of the interviewees, (3) drug treatment interventions received by the interviewees, and (4) problems encountered by the interviewees when they return to society.

  • In-depth personal interviewOther

    The in-depth personal interview was conducted in a semi-structured way. The outline of the interview was formulated from seven aspects: drug use history, drug abstinence history, relapse situation, living conditions, physical and mental health status, return to society status, and active drug abstinence willingness of the drug abstinence personnel. The aim was to understand the needs of drug addicts in terms of family relationship, peer relationship, history of drug use, history of drug withdrawal, employment, economy, social support network, psychology, and assistance.

  • ColloquiaOther

    The colloquia were carried out in the form of group interviews, 1-2 people from each different institution were selected to participate, and the number of people in each colloquium was controlled to be between 6 and 12.

    The colloquia mainly focused on: ① The status quo of the implementation of the local drug drug treatment policy, ② the status quo of the compulsory isolation drug treatment work, ③ the status quo of the work of social workers for drug drug treatment, ④ the status quo of the work of community health centers, ⑤ the operation of various mechanisms in the work of various units, and ⑥ what content in the drug control work needs assistance from other departments and what external resources are needed.

Study groups in NCT06132555
Study groupRoleWhat they receive
Drug abusersDrug abusers who registered in any of the 80 streets and 40 towns selected according to the economic level and population distribution of each city and other reference standards have been included in the study. A total of 6906 valid questionnaires have been collected. The interviewees were selected from 5000 participants in the quantitative questionnaire. Priority is given to drug users who have abstained for more than three years, and all age groups under 30 years old, between 30 and 50 years old and over 50 years old are covered.
Receives: Other: Online questionnaire survey; Other: In-depth personal interview
Drug rehabilitation institutionsThe drug rehabilitation institutions included social work organization, compulsory detoxification center and rehabilitation center, which were selected according to the specific conditions of the selected cities, and the final number of participants was determined according to the personnel Settings of these institutions.
Receives: Other: Colloquia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health status

    The main indicator of health status is the Brief Symptom Inventory-18 (BSI-18) scale, a simplified version of the commonly used psychological evaluation scale SCL-90, consisting of 18 items that are answered on a Likert scale of 0 to 4 points. A higher total score on the BSI-18 indicates a higher level of psychological distress for the respondent.

    Measured: Baseline

Secondary outcomes (4)
  1. Socio-demographic information of drug abusers

    The socio-demographic data collected through the structural questionnaire includes gender, age, education level, income, family size and health status of drug abusers.

    Measured: Baseline

  2. Withdrawal symptoms

    The symptoms that the participants experienced during they quit the drugs. A checklist including 18 symptoms was used the measure the withdrawal symptoms with a Likert scale of 1 to 5 points. A higher score indicates more serious the participants experienced certain withdrawal symptoms.

    Measured: Baseline

  3. Addiction treatment

    The treatment that the participants ever received. A checklist including 4 common treatments used with a Likert scale of 0 to 4 points. A higher score indicates more effective in treating the drug abuse.

    Measured: Baseline

  4. Barriers and support on returning to social

    The barriers and support that the participants experienced when they tried to return to social. A checklist including 8 common barriers and 5 common support with a Likert scale of 1 to 4 points. A higher score indicates more serious or more necessary to the participants.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2023
  2. Study start15 Nov 2023 (estimated)
  3. Primary completionJul 2024 (estimated)
  4. Study completionAug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
7,106 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06132555
Sponsor's protocol ID
WXIA-001
Status last verified
Nov 2023
First submitted
13 Oct 2023
Last updated
15 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The non-identified individual participant data will be shared after the outcomes have been published.

Questions about this trial

What is this clinical trial studying?

An observational study of Drug Use, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wei Xia, PhD (18823359471, xiaw23@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health status (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in